These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders. Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894 [TBL] [Abstract][Full Text] [Related]
27. The role of CXC chemokines and their receptors in the progression and treatment of tumors. Zhu Q; Han X; Peng J; Qin H; Wang Y J Mol Histol; 2012 Dec; 43(6):699-713. PubMed ID: 22752457 [TBL] [Abstract][Full Text] [Related]
28. Chemokine biology in cancer. Balkwill F Semin Immunol; 2003 Feb; 15(1):49-55. PubMed ID: 12495640 [TBL] [Abstract][Full Text] [Related]
29. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Lazennec G; Richmond A Trends Mol Med; 2010 Mar; 16(3):133-44. PubMed ID: 20163989 [TBL] [Abstract][Full Text] [Related]
30. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757 [TBL] [Abstract][Full Text] [Related]
31. The good and the bad of chemokines/chemokine receptors in melanoma. Richmond A; Yang J; Su Y Pigment Cell Melanoma Res; 2009 Apr; 22(2):175-86. PubMed ID: 19222802 [TBL] [Abstract][Full Text] [Related]
32. Canonical and atypical chemokine receptors in the neutrophil life cycle. Di Donato R; Bonecchi R; Albano F Cytokine; 2023 Sep; 169():156297. PubMed ID: 37453326 [TBL] [Abstract][Full Text] [Related]
33. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting. Lee HJ; Song IC; Yun HJ; Jo DY; Kim S World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647 [TBL] [Abstract][Full Text] [Related]
34. Chemokines as effector and target molecules in vascular biology. Sozzani S; Del Prete A; Bonecchi R; Locati M Cardiovasc Res; 2015 Aug; 107(3):364-72. PubMed ID: 25969393 [TBL] [Abstract][Full Text] [Related]
36. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells. Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109 [TBL] [Abstract][Full Text] [Related]
37. Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis. Valdivia-Silva J; Chinney-Herrera A Int Rev Cell Mol Biol; 2024; 388():124-161. PubMed ID: 39260935 [TBL] [Abstract][Full Text] [Related]
38. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins. Nasser MW; Elbaz M; Ahirwar DK; Ganju RK Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887 [TBL] [Abstract][Full Text] [Related]
39. Chemokines: novel targets for breast cancer metastasis. Ali S; Lazennec G Cancer Metastasis Rev; 2007 Dec; 26(3-4):401-20. PubMed ID: 17717637 [TBL] [Abstract][Full Text] [Related]
40. Chemokines in tumor proximal fluids. Kotyza J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):41-49. PubMed ID: 28115749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]